BioCentury
ARTICLE | Clinical News

Talvesta talotrexin: Suspended Phase I/II enrollment

March 26, 2007 7:00 AM UTC

HNAB suspended enrollment in the Phase II portion of an open-label, U.S. Phase I/II trial after incidences of leukoencephalopathy, including one patient who died, were seen in the Phase I trial portio...